Reglan FDA Warning | Tardive Dyskinesia Video Reglan News

Posted by Steve Fields on July 12th, 2009

Reglan And The FDA Warning In February 2009, the U.S. Food and Drug Administration (FDA) issued a mandate that required a black box warning for the branded drug Reglan. This type of warning represents the FDA’s highest level of concern  continue reading

Reglan Side Effects and Children

Reglan side effects in infants and children has been reported in patients receiving Reglan and the generic drug metoclopramide. Children are often prescribed metoclopramide drugs to treat acid reflux (gastroesophageal reflux) and erosive esophagitis. Current package labeling warns of the Reglan dangers of the movement disorder tardive dyskinesia with chronic metoclopramide (Reglan) treatment. find out more

Contact Us for A Free Consultation

Please fill out our contact form and a Reglan lawyer will contact you for a free no-obligation case review.

Requesting a free legal consultation does not create an attorney-client relationship and you are not considered a client until a representation agreement has been signed and your case has been accepted.

State Resources

Statute of Limitations

Reglan FDA Warning

The FDA recently announced a "black box" Reglan warning for drugs that contain metoclopramide which is used to treat gastrointestinal problems and nausea. There has been an increasing concern over patients developing the movement disorder tardive dyskinesia following extended use of the Reglan drug. find out more